FDA approves allergy drug to lessen severity of reactions to peanuts, dairy, other foods

The U.S. Food and Drug Administration has given the injectable Xolair (omalizumab) the green light for use in decreasing the risk of life-threatening reactions to certain foods. Doctors weighed in.

Related Keywords

California ,United States ,Baltimore ,Maryland ,New York ,Johns Hopkins University ,New Hyde Park ,Stony Brook ,America ,Americans ,Susan Schuval ,Roberta Wood ,Fred Davis ,Kenneth Mendez ,Division Of Pulmonology ,Johns Hopkins University School Of Medicine ,Drug Administration ,Genentech ,Allergy Foundation Of America ,Northwell Health ,Division Of Pediatric Allergy ,Centers For Disease ,Join Fox News ,Pediatric Allergy ,Johns Hopkins University School ,Fox News ,Allergy Foundation ,Fox News Digital ,Critical Care ,Drug Evaluation ,Disease Control ,Stony Brook Children ,Long Island ,News Digital ,